4//SEC Filing
McGilley Meg 4
Accession 0001209191-07-056952
CIK 0001339455other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 6:59 PM ET
Size
10.0 KB
Accession
0001209191-07-056952
Insider Transaction Report
Form 4
McGilley Meg
VP, CFO, Treasurer
Transactions
- Exercise/Conversion
Common Stock
2007-10-01$1.20/sh+1,000$1,200→ 1,000 total - Exercise/Conversion
Stock Option (right to buy)
2007-10-01−1,000→ 8,500 totalExercise: $1.20Exp: 2014-06-27→ Common Stock (1,000 underlying) - Sale
Common Stock
2007-10-01$10.17/sh−1,000$10,170→ 0 total
Holdings
- 1,166(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/12/2007.
- [F2]166 shares of common stock subject to the option are vested and exercisable as of October 3, 2007 and approximately 1,041 vest and become exercisable on the first day of each month.
- [F3]Not applicable to this transaction.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001346900
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 6:59 PM ET
- Size
- 10.0 KB